Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis

1. Kim, Y.H.
2. Prince, H.M.
3. Whittaker, S.
4. Horwitz, S.M.
5. Duvic, M.
6. Bechter, O.
7. Sanches, J.A.
8. Stadler, R.
9. Scarisbrick, J.
10. Quaglino, P.
11. Zinzani, P.L.
12. Wolter, P.
13. Eradat, H.
14. Pinter-Brown, L.C.
15. Ortiz-Romero, P.L.
16. Akilov, O.E.
17. Trotman, J.
18. Taylor, K.
19. Weichenthal, M.
20. Walewski, J.
21. Fisher, D.
22. McNeeley, M.
23. Gru, A.A.
24. Brown, L.
25. Palanca-Wessels, M.C.
26. Lisano, J.
27. Onsum, M.
28. Bunn, V.
29. Little, M.
30. Trepicchio, W.L.
31. Dummer, R.
32. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.EJCA.2021.01.054 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus